Oncotelic Therapeutics Announces CEO To Discuss Proprietary
AGOURA HILLS, Calif., Nov. 28, 2023 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) (
Stay updated with breaking news from Pointr Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AGOURA HILLS, Calif., Nov. 28, 2023 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) (
AGOURA HILLS, Calif., Aug. 23, 2023 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) ("Oncotelic", the "Company" or "We" or “Our”), announced...
AGOURA HILLS, Calif., Aug. 17, 2022 -- Oncotelic Therapeutics, Inc. , developer of treatments for rare and orphan indications, including Parkinson Disease and various cancers, today announced that... | August 17, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.